BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36513904)

  • 41. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
    Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
    Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline BAP1 mutations predispose to renal cell carcinomas.
    Popova T; Hebert L; Jacquemin V; Gad S; Caux-Moncoutier V; Dubois-d'Enghien C; Richaudeau B; Renaudin X; Sellers J; Nicolas A; Sastre-Garau X; Desjardins L; Gyapay G; Raynal V; Sinilnikova OM; Andrieu N; Manié E; de Pauw A; Gesta P; Bonadona V; Maugard CM; Penet C; Avril MF; Barillot E; Cabaret O; Delattre O; Richard S; Caron O; Benfodda M; Hu HH; Soufir N; Bressac-de Paillerets B; Stoppa-Lyonnet D; Stern MH
    Am J Hum Genet; 2013 Jun; 92(6):974-80. PubMed ID: 23684012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
    Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
    Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
    Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR
    Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos.
    Brandi G; Deserti M; Palloni A; Turchetti D; Zuntini R; Pedica F; Frega G; De Lorenzo S; Abbati F; Rizzo A; Di Marco M; Massari F; Tavolari S
    Cancer Genet; 2020 Oct; 248-249():57-62. PubMed ID: 33093002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
    Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
    Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germline BAP1 mutations misreported as somatic based on tumor-only testing.
    Abdel-Rahman MH; Rai K; Pilarski R; Davidorf FH; Cebulla CM
    Fam Cancer; 2016 Apr; 15(2):327-30. PubMed ID: 26748926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
    Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
    BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant Peripheral Nerve Sheath Tumor in a Patient With BAP1 Tumor Predisposition Syndrome.
    Kaszuba MC; Pulido JS; Folpe AL; Pichurin PN; Goodenberger ML; Spinner RJ
    World Neurosurg; 2018 Jan; 109():362-364. PubMed ID: 29061454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
    Cheung M; Kadariya Y; Talarchek J; Pei J; Ohar JA; Kayaleh OR; Testa JR
    Cancer Lett; 2015 Dec; 369(2):261-5. PubMed ID: 26409435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case.
    Ravanpay AC; Barkley A; White-Dzuro GA; Cimino PJ; Gonzalez-Cuyar LF; Lockwood C; Halasz LM; Hisama FM; Ferreira M
    World Neurosurg; 2018 Nov; 119():402-415. PubMed ID: 29981911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.
    Mochel MC; Piris A; Nose V; Hoang MP
    Am J Clin Pathol; 2015 Jun; 143(6):901-4. PubMed ID: 25972334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated Histogenetic Analysis Reveals
    Bochtler T; Endris V; Reiling A; Leichsenring J; Schweiger MR; Klein S; Stögbauer F; Goeppert B; Schirmacher P; Krämer A; Stenzinger A
    J Natl Compr Canc Netw; 2018 Jun; 16(6):677-682. PubMed ID: 29891518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
    Carbone M; Flores EG; Emi M; Johnson TA; Tsunoda T; Behner D; Hoffman H; Hesdorffer M; Nasu M; Napolitano A; Powers A; Minaai M; Baumann F; Bryant-Greenwood P; Lauk O; Kirschner MB; Weder W; Opitz I; Pass HI; Gaudino G; Pastorino S; Yang H
    PLoS Genet; 2015 Dec; 11(12):e1005633. PubMed ID: 26683624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene of the month: BAP1.
    Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D
    J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in
    Walpole S; Hayward NK; Pritchard AL; Johansson PA
    JCO Clin Cancer Inform; 2021 Jan; 5():143-154. PubMed ID: 33513031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germline mutation in the TP53 gene in uveal melanoma.
    Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I
    Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
    Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
    J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
    Wadt KA; Aoude LG; Johansson P; Solinas A; Pritchard A; Crainic O; Andersen MT; Kiilgaard JF; Heegaard S; Sunde L; Federspiel B; Madore J; Thompson JF; McCarthy SW; Goodwin A; Tsao H; Jönsson G; Busam K; Gupta R; Trent JM; Gerdes AM; Brown KM; Scolyer RA; Hayward NK
    Clin Genet; 2015 Sep; 88(3):267-72. PubMed ID: 25225168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.